The prevalence of nausea and vomiting in patients with advanced cancer varies, but it generally increases towards the end of life. Nausea and vomiting can be distressing and debilitating for patients, and can affect quality of life significantly. This article discusses the assessment of nausea and vomiting, current understanding of the emetic pathways, and pharmacological management of nausea and vomiting in patients with advanced cancer at the end of life.
Nursing Standard. 32, 10, 53-63. doi: 10.7748/ns.2017.e10993Correspondence
This article has been subject to external double-blind peer review and checked for plagiarism using automated softwareConflict of interest
Prepare for revalidation: read this CPD article, answer the questionnaire and write a reflective account: rcni.com/reflective-accountTo write a CPD article
Please email email@example.com. Guidelines on writing for publication are available at: rcni.com/writeforus
Received: 24 August 2017
Accepted: 19 September 2017
Alternatively, you can purchase access to this article for the next seven days. Buy now